Markus J. Cappel

2012

In 2012, Markus J. Cappel earned a total compensation of $1.8M as Chief Business Officer and Treasurer at ChemoCentryx, a 171% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$96,790
Option Awards$1,322,198
Salary$354,543
Other$690
Total$1,774,221

Cappel received $1.3M in option awards, accounting for 75% of the total pay in 2012.

Cappel also received $96.8K in non-equity incentive plan, $354.5K in salary and $690 in other compensation.

Rankings

In 2012, Markus J. Cappel's compensation ranked 3,960th out of 11,487 executives tracked by ExecPay. In other words, Cappel earned more than 65.5% of executives.

ClassificationRankingPercentile
All
3,960
out of 11,487
66th
Division
Manufacturing
1,372
out of 4,253
68th
Major group
Chemicals And Allied Products
308
out of 1,198
74th
Industry group
Drugs
183
out of 920
80th
Industry
Pharmaceutical Preparations
141
out of 700
80th
Source: SEC filing on March 29, 2013.

Cappel's colleagues

We found three more compensation records of executives who worked with Markus J. Cappel at ChemoCentryx in 2012.

2012

Thomas Schall

ChemoCentryx

Chief Executive Officer

2012

Susan Kanaya

ChemoCentryx

Chief Financial Officer

2012

Petrus Bekker

ChemoCentryx

Senior Vice President of Medical and Clinical Affairs

News

In-depth

You may also like